During the past decade, Norton Hospital Pavilion and Medical Campus conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 35 clinical trials were completed, i.e. on average, 102.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 27 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Hospital Pavilion and Medical Campus" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Gynecologic Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "NRG Oncology" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Hospital Pavilion and Medical Campus" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Norton Hospital Pavilion and Medical Campus" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (7 trials), "Stage IV Primary Peritoneal Cancer AJCC v7" (7 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (6 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials). Many other conditions were trialed in "Norton Hospital Pavilion and Medical Campus" in a lesser frequency.

Most popular intervention types in "Norton Hospital Pavilion and Medical Campus" are "Drug" (52 trials), "Other" (38 trials), "Biological" (21 trials), "Radiation" (15 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (19 trials), "Paclitaxel" (16 trials), "Carboplatin" (12 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "Norton Hospital Pavilion and Medical Campus" are 43 trials for "All" genders, 26 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Norton Hospital Pavilion and Medical Campus". undefined are not yet recruiting, 7 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Norton Hospital Pavilion and Medical Campus, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Hospital Pavilion and Medical Campus, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Norton Hospital Pavilion and Medical Campus has several departments that took part in Clinical trials: "Kentuckiana Pulmonary Associates" - 42 trials, "Norton Cancer Institute, St Matthews Campus" - 24 trials, "Norton Cancer Institute-Downtown" - 8 trials, "Norton Cancer Institute, Audubon Hospital Campus" - 4 trials, "Norton Cancer Institute Pharmacy, Downtown Pharmacy" - 3 trials, "Norton Cancer Institute-Brownsboro" - 3 trials, "Norton Cancer Institute, Brownsboro Hospital Campus" - 3 trials, "Norton Cancer Institute - Saint Matthews,4955 Norton Healthcare Blvd" - 2 trials, "Norton Cancer Institute - Saint Matthews,676 S. Floyd Street" - 2 trials